Introducing Newest-Generation Products For Advancing Coronary Artery Disease Treatment Industry Trends Gaining Momentum in the Global Drug Eluting Balloons Catheters Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Drug Eluting Balloons Catheters Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the market size for drug eluting balloons catheters has experienced significant expansion. An increase from $1.43 billion in 2024 to $1.66 billion in 2025 is predicted, with a compound annual growth rate (CAGR) of 16.0%. This historical growth can be credited to factors such as the rise in respiratory disorders, advantages over traditional inhalers, preference for dpis among patients, government efforts towards respiratory health, strategic alliances and partnerships, advancements in drug formulations, and an aging population.

Drug Eluting Balloons Catheters Market Size Forecast: What's the Projected Valuation by 2029?
The market for drug eluting balloons catheters is projected to experience substantial expansion in the coming years, with an expected value of $2.61 billion in 2029, and a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this rise during the forecast period include an increase in respiratory disorders, a growing elderly population, heightened awareness and education, the growth of markets in emerging economies, personalized drug formulations, regulatory backing and compliance, along with innovations in packaging and design. Future trends predicted for this period encompass smart inhalers with connectivity, a shift towards breath-actuated inhalers, emphasis on the needs of pediatric and geriatric patients, delivery of biologics, and eco-friendly inhaler designs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

What Are the Drivers Transforming the Drug Eluting Balloons Catheters Market?
The surge in peripheral and cardiovascular diseases is anticipated to drive the progression of the drug-eluting balloon catheter market. Conditions such as Cardiovascular diseases (CVDs), which affect the heart and the circulatory system, along with peripheral artery disease (PAD), which leads to decreased blood flow mainly in the limbs, are on the rise. Applying drug-eluting balloon catheters can treat coronary artery disease (CAD) effectively. These catheters employ semi-compliant angioplasty balloons that carry an anti-proliferative substance that combats restenosis when it enters the vessel. As per the statistics from the Centers for Disease Control and Prevention in May 2024, heart disease caused the death of 702,880 individuals in 2022, making up one in five deaths. Every year, around 805,000 heart attacks were reported in the United States, out of which 605,000 had their first one, and 200,000 were the individuals who had already experienced it before. Therefore, the escalation in peripheral and cardiovascular diseases is adding to the growth of the drug-eluting balloon catheter market. As for the Drug Eluting Balloons Catheters Market Driver, the heightened demand for minimally invasive procedures is set to boost the drug-eluting balloon catheter market's expansion. Implementing minimally invasive surgical measures, which involve only small cuts, lead to faster wound healing, less pain, and diminished chances of infection. Drug-eluting balloons are employed in these minimal procedures, delivering medication straight to the treatment area, preventing restenosis, and enhancing the success rate of vascular interventions. For example, data shared by minimally invasive medical product developer, Intuitive Surgical Inc. in January 2023, revealed that surgical procedures performed using Vinci surgical systems climbed by around 18%, from 1,594,000 in 2021 to 1,875,000 in 2022. Moreover, the American Society of Plastic Surgeons confirmed that in the US, the number of cosmetic minimally invasive procedures increased to 23,672,269 in 2022. Therefore, the mounting demand for minimally invasive procedures is contributing to the growth of the drug-eluting balloon catheter market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp

What Long-Term Trends Will Define the Future of the Drug Eluting Balloons Catheters Market?
Leading firms in the drug-eluting balloon catheter market are escalating their efforts to innovate the most recent generation of products using cutting-edge technologies. This is geared towards securing a competitive advantage. In March 2024, for example, Boston Scientific Corporation, a US-based multinational that specializes in biomedical/biotechnological engineering and production of medical devices, secured the approval of US Food and Drug Administration (FDA) for their AGENT Drug-Coated Balloon (DCB). This marked a milestone as the first drug-coated coronary balloon to be made accessible in the U.S for treating in-stent restenosis (ISR) - a condition where plaque or scar tissue obstructs a stented vessel. The AGENT DCB is distinctive due to its paclitaxel coating that delivers a therapeutic dosage to the vessel wall, thereby reducing the recurrence of ISR without necessitating extra stents or radiation. Clinical studies showed a decrease in heart attack risk by 49% at the target location and reported minimal adverse incidents.

Which Segments in the Drug Eluting Balloons Catheters Market Offer the Most Profit Potential?
The drug eluting balloons catheters market covered in this report is segmented -

1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters
2) By Drug: Paclitaxel, Sirolimus, Other Drugs
3) By Raw Material: Nylon, Polyurethane, Other Raw Materials
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

Subsegments:
1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters, Plain Balloon Catheters
2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters, Angioplasty Balloon Catheters
3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13429&type=smp

Which Firms Dominate the Drug Eluting Balloons Catheters Market by Market Share and Revenue in 2025?
Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

Which Regions Offer the Highest Growth Potential in the Drug Eluting Balloons Catheters Market?
North America was the largest region in the drug eluting balloons catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13429

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.